Lupus overwhelmingly affects women of childbearing age, but it can develop in anyone. An estimated 1.5 million Americans and at least five million people worldwide live with some form of lupus, and the vast majority are women between 15 and 45 years old. Your sex, race, family history, and certain environmental exposures all shape your risk.
Women Are Far More Likely to Develop Lupus
The gender gap in lupus is one of the most dramatic in all of medicine. Overall, roughly 9 women are diagnosed for every 1 man. But that ratio isn’t constant across a lifetime. Before puberty, boys and girls develop lupus at nearly equal rates, with a ratio close to 1:1. The gap widens sharply during the reproductive years, peaking around 9 or 10 to 1 in the fourth decade of life, then narrows again after menopause.
This pattern points strongly to hormones. Estradiol, the most potent form of estrogen, directly influences how the immune system behaves. It affects the production of immune cells, antibody levels, and the body’s ability to distinguish its own tissue from foreign invaders. In healthy people, estradiol helps maintain a type of immune cell that keeps the system in check. In people with lupus, that protective response is blunted, which may allow the immune system to attack the body’s own organs and tissues. The rise in lupus risk during peak estrogen years, and its decline afterward, fits this hormonal picture closely.
Race and Ethnicity Matter Significantly
Lupus does not affect all racial and ethnic groups equally. Data from the California Lupus Surveillance Project illustrates how wide the gap is. Among Black residents of San Francisco County, the prevalence was 241 per 100,000 people, compared to 55 per 100,000 among white residents. That’s more than four times the rate. Hispanic and Asian/Pacific Islander populations fell in between, with prevalence rates of about 95 and 91 per 100,000, respectively. American Indian and Alaska Native populations also have elevated rates, though smaller sample sizes make precise estimates harder to pin down.
These differences aren’t just about who gets lupus. They also affect how severe it is. Black patients, for example, tend to develop lupus at younger ages and are more likely to experience kidney involvement, which is one of the most serious complications. The reasons are likely a combination of genetic susceptibility, socioeconomic factors that delay diagnosis, and differences in access to care.
Age of Onset: Mostly Young Adults, but Not Always
Most people develop lupus between ages 15 and 45, which overlaps with the reproductive years. The average age at diagnosis for women ranges from about 28 to 43, while men tend to be diagnosed slightly later, with averages ranging from 26 to 55 depending on the population studied.
About 15% to 20% of all lupus cases are diagnosed in childhood, typically around ages 12 to 15. Childhood-onset lupus tends to run a more aggressive course than adult-onset disease, with higher rates of kidney involvement (43% to 83% of pediatric cases compared to 27% to 67% of adult cases), more frequent fevers, and a greater need for intensive treatment. Children with lupus also show a stronger genetic component and a more active inflammatory signature, which likely explains the more severe disease pattern.
Family History Raises Your Risk
Lupus is not directly inherited like eye color, but genetics play a clear role. If you have a first-degree relative with lupus (a parent, sibling, or child), your risk is meaningfully higher than the general population’s. Between 5 and 13 out of every 100 people with a family history of lupus will eventually develop it themselves. For children whose mothers have lupus specifically, about 5 out of 100 will be diagnosed.
Those numbers mean the vast majority of people with a family connection to lupus will never develop it. But the risk is high enough that people with affected relatives should be aware of early symptoms, particularly joint pain, fatigue, skin rashes, and unexplained fevers.
Men Get Lupus Too, and Often Fare Worse
Because lupus is so strongly associated with women, men are frequently diagnosed later. Doctors may not consider lupus as quickly in a male patient presenting with joint pain or fatigue, which means more time for the disease to cause damage before treatment begins. Men with lupus are more likely to experience serious organ involvement, including kidney disease, cardiovascular complications, and neuropsychiatric symptoms. Studies consistently show higher mortality rates in men with lupus compared to women, particularly from kidney and blood-related complications.
Men with lupus are also more likely to be of African descent, and they tend to present with more fever, weight loss, and high blood pressure at diagnosis. The combination of delayed diagnosis and more aggressive organ involvement gives male lupus a more complex clinical course overall.
Environmental Triggers That Raise Risk
Genetics load the gun, but environmental exposures often pull the trigger. The strongest evidence links several specific factors to increased lupus risk.
- Smoking: Current smokers have about 1.5 times the risk of developing lupus compared to nonsmokers, and they’re four times more likely to produce certain antibodies associated with the disease.
- Silica exposure: People who work with silica dust (common in construction, mining, and sandblasting) face elevated risk, with studies showing a dose-response relationship, meaning more exposure leads to higher risk.
- Hormonal medications: Oral contraceptives and postmenopausal hormone therapy are both associated with increased lupus risk, consistent with the broader role estrogen plays in the disease.
- Pesticides and solvents: Frequent pesticide use (at least monthly) roughly doubles the risk. Extended childhood residence on a farm is also associated with a 1.8 times greater risk. Occupational solvent exposure shows similar patterns.
- Air pollution: Fine particulate pollution has been linked to higher rates of autoimmune diseases including lupus in urban populations.
Infections, particularly Epstein-Barr virus (the virus that causes mono), are suspected to play a role as well, though the evidence is less definitive. Mercury exposure has also been flagged in case-control studies.
Drug-Induced Lupus
Some medications can trigger a lupus-like condition that mimics many of the symptoms of systemic lupus but typically resolves after the medication is stopped. The most common culprits are certain heart rhythm and blood pressure medications, a tuberculosis drug, some anti-inflammatory drugs used for autoimmune conditions, and the antibiotic minocycline. Certain cancer immunotherapy drugs can also trigger it.
The key distinction is that drug-induced lupus usually clears up within days to weeks of discontinuing the responsible medication. It rarely involves the kidney or brain damage seen in systemic lupus, making it a fundamentally different condition despite the shared name.